Gapping up
In reaction to strong earnings/guidance:
- AMBA +15.1%, WDAY +8.7%, VMW +5.9%, SPLK +3.2%, HPQ +2.1%, DVMT +1.9%, T +1.2%, PANW +0.5%
Other news:
- CCRC +4.7% (indicated higher after confirming it has engaged advisors to review and evaluate previously announced $16/share acquisition proposal)
- HIMX +3.6% (announces that its Chairman Dr. Biing-Seng Wu intends to use his personal funds to purchase up to approximately $5 mln of the Company's American Depositary Shares in the open market)
- SRRA +3.5% (reported preclinical efficacy for immunotherapy combination with its Chk1 inhibitor SRA737)
- EDIT +1% (FDA has accepted the Investigational New Drug application for EDIT-101)
Analyst comments:
- WWE +2.7% (upgraded to Overweight from Neutral at JP Morgan)
- COUP +2.3% (upgraded to Buy from Hold at Loop Capital)
- MYGN +2.1% (upgraded to Neutral from Sell at Goldman)
- CUB +1.6% (upgraded to Overweight from Neutral at JP Morgan)
- CRSP +1.5% (initiated with a Buy at Needham)
- UAA +1.3% (upgraded to Market Perform from Underperform at Wells Fargo)
- ABT +1.1% (upgraded to Buy from Neutral at Goldman)
- COOP +0.8% (initiated with Buy at BTIG)